AU2001255597A1 - Methods and compositions for the diagnosis of schizophrenia - Google Patents

Methods and compositions for the diagnosis of schizophrenia

Info

Publication number
AU2001255597A1
AU2001255597A1 AU2001255597A AU5559701A AU2001255597A1 AU 2001255597 A1 AU2001255597 A1 AU 2001255597A1 AU 2001255597 A AU2001255597 A AU 2001255597A AU 5559701 A AU5559701 A AU 5559701A AU 2001255597 A1 AU2001255597 A1 AU 2001255597A1
Authority
AU
Australia
Prior art keywords
schizophrenia
diagnosis
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255597A
Inventor
Anne S. Bassett
Linda M. Brzustowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of AU2001255597A1 publication Critical patent/AU2001255597A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/302—Schizophrenia
AU2001255597A 2000-04-21 2001-04-23 Methods and compositions for the diagnosis of schizophrenia Abandoned AU2001255597A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19910400P 2000-04-21 2000-04-21
US60199104 2000-04-21
PCT/US2001/013082 WO2001080720A2 (en) 2000-04-21 2001-04-23 Methods and compositions for the diagnosis of schizophrenia

Publications (1)

Publication Number Publication Date
AU2001255597A1 true AU2001255597A1 (en) 2001-11-07

Family

ID=22736226

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255597A Abandoned AU2001255597A1 (en) 2000-04-21 2001-04-23 Methods and compositions for the diagnosis of schizophrenia

Country Status (2)

Country Link
AU (1) AU2001255597A1 (en)
WO (1) WO2001080720A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2592473A1 (en) 2004-12-30 2006-07-06 University Of Louisville Research Foundation, Inc. Genetic markers of schizophrenia

Also Published As

Publication number Publication date
WO2001080720A3 (en) 2002-02-07
WO2001080720A2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001231199A1 (en) Compositions and methods for the early diagnosis of ovarian cancer
AU2001295503A1 (en) Composition for the elimination of autoreactive b-cells
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
AU2001247196A1 (en) Methods and compositions for detection of disease
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2002249983A1 (en) Compositions and methods for diagnosis of neuropsychiatric disorders
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001257164A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257180A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257179A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001255606A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001255597A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001259127A1 (en) Methods and composition for the diagnosis of schizophrenia
AU2001257176A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257175A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257178A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257183A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257162A1 (en) Methods and compositions for the diagnosis of schizophrenia